Novo Ventures

Novo A/S is an active and independent company in its support of biotech ventures. The aspiration is to bring together the best of both worlds: industry insight and network from our pharma/biotech inheritance combined with a venture capital mindset that focuses on results and value creation.

Novo A/S' portfolio of investments in life science has grown considerably since the company's start. Novo has invested in more than 57 portfolio companies. There is considerable diversity in the portfolio across technologies, products and financial stages. Furthermore, the portfolio is international, currently with more than half the invested capital in North American companies and the rest in Denmark and Europe.

Click here to download Novo Ventures' brochure.

Click here to download Novo Ventures' brochure addendum.

Click here to read the Novo Ventures' section of Annual report 2008

Click here to read the article 'A unique approach to venture investing' (from the Annual Report 2008)

Novo's Annual Report 2008 features two articles on the two portfolio companies, Insound Medical and Ophthotech Corporation.